What are the Historical Developments and Current Growth Metrics of the Cancer Supportive Care Drugs Market?
The cancer supportive care drugs market has seen considerable growth due to a variety of factors.
• The cancer supportive care drugs market has seen steady growth in recent years. It will grow from $20.83 billion in 2024 to $21.85 billion in 2025, at a compound annual growth rate (CAGR) of 4.9%.
This is due to an aging population, the rising prevalence of chemotherapy, growing demand for antiemetics, the increasing use of online pharmacies, and more focus on palliative care and personalized medicine.
What Is The Projected Growth Of The Cancer Supportive Care Drugs Template Market?
The cancer supportive care drugs market is expected to maintain its strong growth trajectory in upcoming years.
• The cancer supportive care drugs market is expected to grow steadily to $26.1 billion by 2029, with a CAGR of 4.5%.
The market's growth is driven by increased awareness of the side effects of cancer treatments, more breast cancer cases, specific medication plans, online consultations, improvements in pharmaceutical supply chains, and growing cancer survivor populations. Trends include advancements in targeted therapies, integration of behavioral interventions, survivorship care plans, nutritional support, pain management innovations, and symptom monitoring platforms.
What Are The Key Drivers Fueling Growth In The Cancer Supportive Care Drugs Market?
The improved survival rate of cancer patients is expected to support the growth of the cancer supportive care drugs market. As survival rates increase with early detection and better treatments, patients require drugs to manage side effects like pain and nausea. The National Cancer Institute projected a 24.4% rise in cancer survivors by 2032, driving the demand for supportive care drugs.
What Are The Principal Market Segments In The Global Cancer Supportive Care Drugs Industry?
The cancer supportive care drugs market covered in this report is segmented –
1) By Type: Erythropoiesis Stimulating Agents, Granulocyte Colony Stimulating Factors, Antiemetics, Bisphosphonates, Opioids, Nonsteroidal Anti Inflammatory Drugs, Other Types
2) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Other Channels
Subsegments:
1) By Erythropoiesis Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa, Methoxy Polyethylene Glycol-Epoetin Beta
2) By Granulocyte Colony Stimulating Factors: Filgrastim, Pegfilgrastim, Lenograstim
3) By Antiemetics: 5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Corticosteroids
4) By Bisphosphonates: Zoledronic Acid, Pamidronate, Ibandronate
5) By Opioids: Morphine, Fentanyl, Oxycodone
6) By Nonsteroidal Anti Inflammatory Drugs (NSAIDs): Ibuprofen, Diclofenac, Celecoxib
7) By Other Types: Steroids, Anxiolytics, Appetite Stimulants
Pre-Book The Cancer Supportive Care Drugs Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Cancer Supportive Care Drugs Market?
Companies in the cancer support care drugs market are developing combination therapies to address the complexity of cancer treatment. For example, in November 2023, Merck, a US-based pharmaceutical company, received FDA approval for KEYTRUDA, an anti-PD-1 therapy combined with gemcitabine and cisplatin for treating advanced biliary tract cancer (BTC). This combination therapy showed positive results in improving overall survival, offering a new treatment option for BTC patients.
Who Are the Key Players In The Cancer Supportive Care Drugs Market?
Major companies operating in the cancer supportive care drugs market are:
• Pfizer Inc.
• Johnson & Johnson
• Merck
• AbbVie Inc.
• Bayer AG
• Sanofi SA
• Bristol Myers Squibb Company
• AstraZeneca plc
• Novartis AG
• F Hoffmann-La Roche Ltd.
• Takeda Pharmaceutical Company Limited
• GlaxoSmithKline plc
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Baxter International Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Astellas Pharma Inc.
• Eisai Co. Ltd.Incyte Corporation
• Exelixis Inc.
• Fagron Group
• Heron Therapeutics Inc.
• Athenex Inc.
• Acrotech Biopharma LLC
What Are The Regional Insights Into The Cancer Supportive Care Drugs Market?
North America was the largest region in the cancer supportive care drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
